Evidence map›Paper›PMID 41660546›Full record

ArticleEuropean heart journal. Imaging methods and practice2026

Quantifying mitral regurgitation in MVP: the added value of three-dimensional continuity equation.

Abdalla Eltayeb A Abdelkader, Amro Alsaid, Ralph Matar, Prajakta Phatak, Janaki Rami Reddy Manne, Zuyue Wang

Abstract read
In one paragraph

Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdalla Eltayeb A AbdelkaderDivision of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA.ORCID https://orcid.org/0000-0002-6362-4553
Amro AlsaidBaylor Scott & White, The Heart Hospital, Plano, TX, USA.
Ralph MatarBaylor Scott & White, The Heart Hospital, Plano, TX, USA.
Prajakta PhatakBaylor Scott & White, The Heart Hospital, Plano, TX, USA.
Janaki Rami Reddy ManneBaylor Scott & White, The Heart Hospital, Plano, TX, USA.
Zuyue WangBaylor Scott & White, The Heart Hospital, Plano, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Quantifying mitral regurgitation (MR) in patients with mitral valve prolapse (MVP) is particularly challenging due to the complex mitral valve anatomy, presence of multiple eccentric jets, and non-holosystolic regurgitation. The continuity equation (CE) offers a potentially more accurate method for assessing MR regurgitant volume in this population. Methods and results: We evaluated patients with MVP and at least moderate MR. Regurgitant volumes (RVol) were quantified using the three-dimensional continuity equation (3D-CE) with direct area measurements and compared with RVol derived from the conventional diameter-based continuity equation (D-CE) and cardiovascular magnetic resonance (CMR). Among 72 patients (mean age 59.7 years, 65% female), bileaflet MVP was present in 86% and MAD in 96%. Multiple MR jets (32%) limited PISA accuracy ( Conclusion: In patients with MVP, incorporating 3D annular measurements into 3D-CE improves agreement with CMR-based volumetric assessment and mitigates overestimation associated with D-CE and PISA-based methods. This approach may be particularly valuable in patients with moderate or moderate-severe MR, in whom conventional echocardiographic parameters are frequently discordant, and supports the role of integrative multimodality imaging in refining MR severity assessment and guiding clinical management. Larger prospective studies are warranted to confirm these findings.

Indexed as

cardiac magnetic resonancecontinuity equationmitral valve prolapsethree-dimensional echocardiographyvolumetric assessment

Identifiers

PMID41660546
PMCPMC12872397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.